Palatin Technologies
PTN
#10824
Rank
S$20.54 M
Marketcap
S$11.54
Share price
-5.36%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -S$7.96 Million

According to Palatin Technologies's latest financial reports the company's current earnings are S$12.88 Million. In 2025 the company made an earning of -S$12.32 Million, an increase over its 2024 earnings that were of -S$34.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$7.96 Million-35.42%
2025 -S$12.32 Million-64.29%
2024 -S$34.5 Million-16.9%
2023 -S$41.52 Million5.99%
2022 -S$39.17 Million-13.7%
2021 -S$45.39 Million33.25%
2020 -S$34.06 Million-172.11%
2019 S$47.22 M2352.33%
2018 S$1.92 M-94.13%
2017 S$32.81 M-154.92%
2016 -S$59.76 Million3.67%
2015 -S$57.64 Million878%
2014 -S$5.9 Million-72.64%
2013 -S$21.55 Million-33.11%
2012 -S$32.21 Million77.71%
2011 -S$18.13 Million
2003 -S$30.69 Million29.93%
2002 -S$23.62 Million36.18%
2001 -S$17.35 Million
1999 -S$14.4 Million6.04%
1998 -S$13.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.56 B-419,974.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.35 B-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.04 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$13.77 Million 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.31 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$0.18 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-S$37.76 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$71.04 Million 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA